Table 4.

Basic demographic and metabolic details of the longitudinal study (study 2) at baseline and end of study

Variables	Baseline		Study End at 27 mo
	Normotensive	Hypertensive	Normotensive	Hypertensive
n	8	8	8	8
Age, yr	5.02 ± 0.16	5.04 ± 0.16
Body wt, kg	9.08 ± 0.62	10.4 ± 0.82	15.7 ± 1.08	16.7 ± 1.28
Body fat, %	15.4 ± 1.27	18.8 ± 1.94	24.6 ± 3.00	30.0 ± 2.32
Waist, cm	36.4 ± 1.71	38.8 ± 2.95	47.3 ± 3.69	51.7 ± 2.56
FBG, mg/dL	64.5 ± 3.17	67.5 ± 2.96	76.1 ± 23.8	87.5 ± 17.5
A1c, %	4.71 ± 0.08	4.79 ± 0.11	5.83 ± 0.75	5.40 ± 0.44
TPC, mg/dL	161 ± 15.6	173 ± 7.67	204 ± 18.9	179 ± 18.4
HDLC, mg/dL	98.4 ± 9.58	115 ± 12.3	120 ± 9.74	113 ± 7.95
TG, mg/dL	37.0 ± 11.9	39.8 ± 5.55	39.9 ± 9.24	57.4 ± 18.4

Values are means ± SE. No significant differences were observed at baseline or at study end (ANCOVA, P > 0.05). A1c, glycosylated hemoglobin; FBG, fasting glucose; HDLC, high-density lipoprotein cholesterol; TG, total plasma triglycerides; TPC, total plasma cholesterol; waist, waist circumference.